Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This is a single and multiple ascending study to characterize the safety, PK, PD and clinical effect in healthy volunteers and participants with Celiac Disease and Eosinophilic Esophagitis.
Epistemonikos ID: ccb637e1bf6f96314216bf4761e7b49a5f4f96b7
First added on: Oct 02, 2023